Warfarin News and Research

RSS
Warfarin is a drug that prevents blood from clotting. It belongs to the family of drugs called anticoagulants (blood thinners).
AGA Medical first-quarter net sales increase 15.4% to $51.3 million

AGA Medical first-quarter net sales increase 15.4% to $51.3 million

VIMOVO delayed-release tablets receive FDA approval

VIMOVO delayed-release tablets receive FDA approval

Researchers use healthy person's complete genome sequence to predict risk for dozens of diseases

Researchers use healthy person's complete genome sequence to predict risk for dozens of diseases

FDA clears Osmetech's eSensor Thrombophilia Risk Test

FDA clears Osmetech's eSensor Thrombophilia Risk Test

Research associates diabetes with atrial fibrillation

Research associates diabetes with atrial fibrillation

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Rheonix announces completion of $12.6 million Series A financing

Rheonix announces completion of $12.6 million Series A financing

Self-monitoring of Coumadin levels reduces risk of blood clots by 50%: Study

Self-monitoring of Coumadin levels reduces risk of blood clots by 50%: Study

Consortium studies gene-drug relationship to determine optimal warfarin doses

Consortium studies gene-drug relationship to determine optimal warfarin doses

Camp Okizu's brain tumor weekend program has new benefactor

Camp Okizu's brain tumor weekend program has new benefactor

IDF awarded NIH grant for advancing knowledge in PIDD through continuance of USIDNET program

IDF awarded NIH grant for advancing knowledge in PIDD through continuance of USIDNET program

Pancreaze Delayed Release Capsules receive FDA approval

Pancreaze Delayed Release Capsules receive FDA approval

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

Clinical testing service for safer dosing of warfarin

Clinical testing service for safer dosing of warfarin

New report assesses optimal future for REMS

New report assesses optimal future for REMS

Novel oral anticoagulants to drive venous thromboembolism drug market to $5 billion in 2018

Novel oral anticoagulants to drive venous thromboembolism drug market to $5 billion in 2018

Roche Diagnostics' CoaguChek XS Plus system granted CLIA-waived status

Roche Diagnostics' CoaguChek XS Plus system granted CLIA-waived status

AGA Medical gets IDE approval to evaluate AMPLATZER Cardiac Plug

AGA Medical gets IDE approval to evaluate AMPLATZER Cardiac Plug

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

GenMark Diagnostics files registration statement with Securities and Exchange Commission

GenMark Diagnostics files registration statement with Securities and Exchange Commission

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.